FDA Drug recall D-0302-2021
N-A-C (N-Acetyl-L-Cysteine, 500 mg, 100 capsules
- FDA Drug
- Class II
- terminated
- Published 2020-11-04
On 2020-11-04 the FDA classified a Class II recall of N-A-C (N-Acetyl-L-Cysteine, 500 mg, 100 capsules by Jarrow Formulas, citing mislabeling of SUS (N-A-C Sustain 600 mg 100 tab) with N-A-C N-Acetyl-L-Cysteine 500 mg, 100 cap.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0302-2021 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2020-10-09 |
| Published | 2020-11-04 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Jarrow Formulas |
| Distribution | US |
Product
N-A-C (N-Acetyl-L-Cysteine, 500 mg, 100 capsules; Veggie Caps, white HDPE bottle with RED label Product # 107002 UPC: 790011070023
Reason
Mislabeling of SUS (N-A-C Sustain 600 mg 100 tab) with N-A-C N-Acetyl-L-Cysteine 500 mg, 100 cap.
Identifiers
| upc | 790011070023 |
|---|---|
| code_info | Lot 65323G20; Expiration: 7/22 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0302-2021%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.